Subgroups
Protocols (4)
Outcomes & scoring
gastrointestinal-appetite-carbohydrate-cravings-severity-perceived-rating-self-reported1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-diabetes-insulin-degludec-high-dose-generic | -15 | 30 | 1 |
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-diabetes-insulin-degludec-high-dose-generic | -30 | 35 | 1 |
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-diabetes-insulin-degludec-high-dose-canagliflozin-insulin-aspart | +60 | 35 | 1 |
glucose-fasting-serum-concentration-mg-per-dl-measured2 evidence rows
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-diabetes-insulin-degludec-high-dose-generic | -60 | 35 | 1 |
| medication-diabetes-insulin-degludec-high-dose-metformin-liraglutide | -70 | 35 | 1 |
glucose-fasting-serum-hyperglycemia-above-two-hundred-milligrams-per-deciliter-detected-binary-self-reported1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-diabetes-insulin-degludec-high-dose-generic | -30 | 30 | 1 |
glucose-fasting-serum-range-one-hundred-to-one-hundred-twenty-five-milligrams-per-deciliter-target-achieved-binary-measured1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-diabetes-insulin-degludec-high-dose-canagliflozin-insulin-aspart | +40 | 35 | 1 |
glucose-stability-worsening-rating-self-reported1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-diabetes-insulin-degludec-high-dose-evening | -20 | 25 | 1 |
Path: medication › diabetes › insulin › degludec › high